OSCR

Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation.

Overview

Authors: Gregory A. Mohl1,2, Gary Dixon1, Emily Marzette1, Justin McKetney3,4,5, Avi J. Samelson1, Carlota Pereda Serras1,6, Julianne Jin1, Nabeela Ariqat1, Andrea Keys1, Cristian Chavira1, Andrew Li1, Steven C. Boggess1, Danielle L. Swaney3,4,5, Martin Kampmann1,7
  1. Institute for Neurodegenerative Diseases, University of California San Francisco,San Francisco, CA USA
  2. Department of Neurology, University of California San Francisco,San Francisco, CA USA
  3. Gladstone Data Science and Biotechnology Institute, The J. David Gladstone Institutes,San Francisco, CA USA
  4. Quantitative Bioscience Institute, University of California San Francisco,San Francisco, CA USA
  5. Department of Cellular and Molecular Pharmacology, University of California San Francisco,San Francisco, CA USA
  6. Bakar Computational Health Sciences Institute, University of California San Francisco,San Francisco, CA USA
  7. Department of Biochemistry and Biophysics, University of California San Francisco,San Francisco, CA USA
Institutions: University of California, San Francisco (United States); Gladstone Institutes (United States)
Journal: NPJ dementia, volume 2, issue 1, article 24
Dates: received 24 August 2025; accepted 6 March 2026; published online 25 April 2026; in print 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s44400-026-00076-w · PMID 42046563 · PMCID PMC13110130 · OpenAlex W7155651581
Open access: hybrid, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: genetics / omics (modality), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions
Keywords: Cell biology, Molecular biology, Neurology, Neuroscience
Topic: Alzheimer's disease research and treatments (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Funding: A.P. Gianni Foundation (Postdoctoral Fellowship); National Institute for Neurological Disorders and Stroke (U54 NS123746, U54 NS100717); national institute on aging (F32 AG063487, R01 AG062359); Alzheimer’s Association (23AARF-1027616); Rainwater Charitable Foundation (Tau Consortium Award); Chan Zuckerberg Initiative (Ben Barres Early Career Acceleration Award)
Citations: cited by 1 paper (Europe PMC); 93 references in the paper

Abstract

Tau aggregation is a hallmark of several neurodegenerative diseases, including Alzheimer’s disease and frontotemporal dementia. There are disease-causing variants of the tau-encoding gene, MAPT, and the presence of tau aggregates is highly correlated with disease progression. However, the molecular mechanisms linking pathological tau to neuronal dysfunction are not well understood. This is in part due to an incomplete understanding of the normal functions of tau in development and aging, and how the associated molecular and cellular processes change in the context of causal disease variants of tau. To address these questions in an unbiased manner, we conducted multi-omic characterization of iPSC-derived neurons harboring the MAPT V337M mutation or MAPT knockdown. RNA-seq, ATAC-seq, and phosphoproteomics revealed that both the V337M mutation and tau knockdown perturbed levels of transcripts and phosphorylation of proteins related to axonogenesis or axon morphology. When we directly measured axonogenesis, we found that both MAPT V337M and MAPT knockdown caused decreased axon length. Surprisingly, we found that neurons with V337M tau had much lower tau phosphorylation than neurons with WT tau. CRISPR-based screens uncovered regulators of tau phosphorylation in neurons and found that factors involved in axonogenesis modified tau phosphorylation in both MAPT WT and MAPT V337M neurons. Intriguingly, the p38 MAPK pathway specifically modified tau phosphorylation in MAPT V337M neurons. We propose that V337M tau perturbs tau phosphorylation and axon morphology pathways that are relevant to the normal function of tau in development, which could contribute to previously reported cognitive changes in preclinical MAPT variant carriers.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

kampmannlab.ucsf.edu/resources

License: none: the authors keep all their rights
State: the link answers, verified on 30 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: the text, “CRISPR screening”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 30 September 2026: the link answers (HTTP 200)
  • 30 September 2026: the link answers (HTTP 200)

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data availability

Data is provided within the manuscript or supplementary information files

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 14 authors, 4 keywords, 6 funders, 90 references.

Cite

This paper

Mohl, G. A., Dixon, G., Marzette, E., McKetney, J., Samelson, A. J., Serras, C. P., Jin, J., Ariqat, N., Keys, A., Chavira, C., Li, A., Boggess, S. C., Swaney, D. L., & Kampmann, M. (2026). Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation. NPJ dementia, 2(1), 24. https://doi.org/10.1038/s44400-026-00076-w

BibTeX

@article{mohl2026multi,
author = {Mohl, Gregory A. and Dixon, Gary and Marzette, Emily and McKetney, Justin and Samelson, Avi J. and Serras, Carlota Pereda and Jin, Julianne and Ariqat, Nabeela and Keys, Andrea and Chavira, Cristian and Li, Andrew and Boggess, Steven C. and Swaney, Danielle L. and Kampmann, Martin},
title = {{Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation}},
journal = {NPJ dementia},
year = {2026},
month = apr,
volume = {2},
number = {1},
pages = {24},
publisher = {Springer Science+Business Media},
issn = {3005-1940},
doi = {10.1038/s44400-026-00076-w},
url = {https://doi.org/10.1038/s44400-026-00076-w},
pmid = {42046563},
pmcid = {PMC13110130}
}

RIS

TY - JOUR
AU - Mohl, Gregory A.
AU - Dixon, Gary
AU - Marzette, Emily
AU - McKetney, Justin
AU - Samelson, Avi J.
AU - Serras, Carlota Pereda
AU - Jin, Julianne
AU - Ariqat, Nabeela
AU - Keys, Andrea
AU - Chavira, Cristian
AU - Li, Andrew
AU - Boggess, Steven C.
AU - Swaney, Danielle L.
AU - Kampmann, Martin
TI - Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation
T2 - NPJ dementia
J2 - NPJ Dement
PY - 2026
DA - 2026/04/25
VL - 2
IS - 1
SP - 24
SN - 3005-1940
PB - Springer Science+Business Media
DO - 10.1038/s44400-026-00076-w
UR - https://doi.org/10.1038/s44400-026-00076-w
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s44400-026-00076-w",
"type": "article-journal",
"title": "Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation",
"container-title": "NPJ dementia",
"author": [
{
"family": "Mohl",
"given": "Gregory A."
},
{
"family": "Dixon",
"given": "Gary"
},
{
"family": "Marzette",
"given": "Emily"
},
{
"family": "McKetney",
"given": "Justin"
},
{
"family": "Samelson",
"given": "Avi J."
},
{
"family": "Serras",
"given": "Carlota Pereda"
},
{
"family": "Jin",
"given": "Julianne"
},
{
"family": "Ariqat",
"given": "Nabeela"
},
{
"family": "Keys",
"given": "Andrea"
},
{
"family": "Chavira",
"given": "Cristian"
},
{
"family": "Li",
"given": "Andrew"
},
{
"family": "Boggess",
"given": "Steven C."
},
{
"family": "Swaney",
"given": "Danielle L."
},
{
"family": "Kampmann",
"given": "Martin"
}
],
"container-title-short": "NPJ Dement",
"volume": "2",
"issue": "1",
"page": "24",
"DOI": "10.1038/s44400-026-00076-w",
"PMID": "42046563",
"PMCID": "PMC13110130",
"ISSN": "3005-1940",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1038/s44400-026-00076-w",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
25
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s40035-021-00270-1
The role of pathological tau in synaptic dysfunction in Alzheimer's diseases.
Journal: Translational neurodegeneration
In common: Alzheimer's / dementia, cellular / molecular, 7 references
[2] doi:10.1186/s12864-022-08502-y [code]
The evolution of microtubule associated proteins - a reference proteomic perspective.
Journal: BMC genomics
In common: genetics / omics, cellular / molecular, 6 references
[3] doi:10.1038/s41380-022-01538-2 [code]
Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport.
Journal: Molecular psychiatry
In common: Alzheimer's / dementia, cellular / molecular, 6 references
[4] doi:10.1016/j.ymthe.2024.01.033
Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
In common: Alzheimer's / dementia, cellular / molecular, 6 references
[5] doi:10.1016/j.cell.2021.12.041
Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.
Journal: Cell
In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 6 references
[6] doi:10.1101/gr.278576.123 [code]
Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a <i>Drosophila</i> knock-in tauopathy model.
Journal: Genome research
In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 6 references
[7] doi:10.1007/s00401-026-03018-1
Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.
Journal: Acta neuropathologica
In common: Alzheimer's / dementia, cellular / molecular, 6 references
[8] doi:10.1186/s13024-024-00731-x
Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.
Journal: Molecular neurodegeneration
In common: cellular / molecular, 6 references
[9] doi:10.1016/j.mcpro.2025.101458 [code]
Proximity Labeling of the Tau Repeat Domain Enriches RNA-Binding Proteins That Are Altered in Alzheimer's Disease and Related Tauopathies.
Journal: Molecular & cellular proteomics : MCP
In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 5 references
[10] doi:10.1016/j.celrep.2024.115013
Development of MAPT S305 mutation human iPSC lines exhibiting elevated 4R tau expression and functional alterations in neurons and astrocytes.
Journal: Cell reports
In common: Alzheimer's / dementia, cellular / molecular, 5 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w.svg)](https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w.svg
   :target: https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w"><img src="https://openscicode.org/badge/doi/10.1038/s44400-026-00076-w.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.